Amine Souadka1, Amina Houmada2, Abdelilah Souadka3. 1. Surgical Oncology department, National Institute of Oncology, Faculté de Médecine, Mohammed V University in Rabat, Morocco. Electronic address: a.souadka@um5s.net.ma. 2. Surgical Oncology department, National Institute of Oncology, Faculté de Médecine, Mohammed V University in Rabat, Morocco. Electronic address: amina.houmada@gmail.com. 3. Private cancer center. Rmel, Salé, Morocco. Electronic address: abdelilah.souadka@gmail.com.
Abstract
Entities:
Keywords:
Breast cancer; EUSOMA; Multidisciplinary team meetings
To the editor.We read with great interest the article written by Mrabti and colleagues [1]. This article tried to describe the pattern of care of breast cancer in morocco reporting the experience of the 2 main public-funded comprehensive oncology centers (INO [2] in Rabat and CM -VI in Casablanca) in this country with a separate evaluation. The authors succeed in comparing the two centers showing the higher performance of INO using well validated criteria EUSOMA [3] and survival outcomes.However, the authors used only 2 surgical criteria of the 9 recommended by the EUSOMA (omitting the most essential which is multidisciplinary discussion [4]) evaluating the expertise of the centers, knowing that the quality of surgery remains the best indicator in managing early stage breast tumors.The authors should also describe more how they managed lost of follow up patients, since only 174 out of 915 (20%) from CM-VI and 343 out of 1205 (28.4%) of INO reached the 3 year recurrence free survival number at risk and this number rapidly decreased to 95 and 179 at 5 years respectively. This biais may certainly decrease the high recurrence free-survival reported in this series.
Authors: E Pons-Tostivint; L Daubisse-Marliac; P Grosclaude; E Oum Sack; J Goddard; C Morel; C Dunet; L Sibrac; C Lagadic; E Bauvin; Y Bergé; C Bernard-Marty; C Vaysse; J L L Lacaze Journal: Breast Date: 2019-06-07 Impact factor: 4.380
Authors: Laura Biganzoli; Lorenza Marotti; Christopher D Hart; Luigi Cataliotti; Bruno Cutuli; Thorsten Kühn; Robert E Mansel; Antonio Ponti; Philip Poortmans; Peter Regitnig; Jos A van der Hage; Yvonne Wengström; Marco Rosselli Del Turco Journal: Eur J Cancer Date: 2017-09-28 Impact factor: 9.162